News

Critical Outcome Technologies said that the gap analysis is conducted prior to an initial meeting with the FDA to identify potential deficiencies in the preclinical development program of

TRP-2 and gp100 are the key components of Scancell’s lead ImmunoBody vaccine for melanoma, SCIB1. As per the agreement, Scancell has agreed to pay the US Public Health

The study results showed that animals receiving subcutaneous injections of Rituximab, incorporated with NexACT, demonstrated a 46% enhancement in bioavailability over Rituximab, alone. Rituximab is a cancer medication

The services Kuehne + Nagel will provide for Boehringer Ingelheim include temperature-controlled road transportation of thermolabile medical products to the Czech Republic, Poland, Hungary, Greece and Croatia. Kuehne

The goal of the research is to develop blood tests for the early detection or more accurate diagnosis of cancer. Aushon 2470 Arrayer has been installed in institutions

JHP Pharma is a specialty pharmaceutical company that manufactures and sells sterile injectable products for the hospital market segment, and provides contract manufacturing of sterile injectable products for

GSK and Dong-A said that the transaction is expected to initially co-promote selected GSK and Dong-A pharmaceutical OTC products for use in primary care. Additional synergies are expected

EntreMed said that the study is expected to be open at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Massachusetts General Hospital and Beth Israel Deaconess Medical Center, all

NVIC called on the FDA to legally require vaccine manufacturers to adhere to binding regulations rather than offering companies non-binding recommendations and to immediately recommend the use of